Immunovia Publishes Interim Report for January-March 2023 :

LUND, Sweden, May 23, 2023 /PRNewswire/ -- 
January-March 2023
Net sales amounted to kSEK 520 divided by sales of tests kSEK 379 and royalties kSEK 141.Net earnings were MSEK -51.7 and... | May 23, 2023

Related Keywords

Sweden , Stockholm , United Kingdom , United States , Switzerland , Swiss , Swedish , Karin Almqwist Liwendahl , Karin Almqvist Liwendahl , Jeff Borcherding , Clinical Scientific Affairs , Immunovia Inc , Extraordinary General Meeting , Karl Stone , Rights Issue , Annual General Meeting , Scientific Affairs , Financial Officer , Immunovia Ab Publ Stock Exchange , News , Information , Press Release , Bay , 023 , Sales , Mounted , O , Bsek , 20 , Divided , Y , F , Tests , 79 , End , Royalties , Earnings , Were , Sek Immvf Se0006091997 ,